Cargando…

Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients

BACKGROUND: Due to the different treatments for low-volume metastatic prostate cancer (PCa) as well as high-volume ones, evaluation of bone metastatic status is clinically significant. In this study, we evaluated the correlation between pre-treatment plasma fibrinogen and the burden of bone metastas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Gan-Sheng, Li, Gang, Li, Yu, Pu, Jin-Xian, Huang, Yu-Hua, Li, Jin-Hu, Yin, Hu-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940101/ https://www.ncbi.nlm.nih.gov/pubmed/31725446 http://dx.doi.org/10.1097/CM9.0000000000000506

Ejemplares similares

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas
por: He, Zhen-Qiang, et al.
Publicado: (2017)

Association of Preoperative Plasma D-Dimer and Fibrinogen and Osteosarcoma Outcome
por: Pu, Yanchuan, et al.
Publicado: (2022)

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
por: wang, Ning, et al.
Publicado: (2021)

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer
por: Thierry, Alain R., et al.
Publicado: (2021)

The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
por: Fan, Dong-Yu, et al.
Publicado: (2021)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
por: Xie, Gan-Sheng, et al.
Publicado: (2016)

Influence of Fibrinogen/Albumin Ratio and Fibrinogen/Pre-Albumin Ratio on Cardiac Autonomic Neuropathy in Type 2 Diabetes
por: Zhao, Subei, et al.
Publicado: (2023)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

Plasma Fibrinogen as a Diagnostic Marker of Infection in Patients with Nonunions
por: Wang, Xiang-Jin, et al.
Publicado: (2020)

Changes and significance of plasma fibrinogen gamma‐chain concentration in preeclampsia patients
por: Zhu, YuLi, et al.
Publicado: (2021)

The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer
por: Bian, Nan-Nan, et al.
Publicado: (2019)

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2019)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
por: Bello, Jibril Oyekunle
Publicado: (2017)

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
por: Ong, Sean, et al.
Publicado: (2021)

Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer
por: Barbier, Michaela C., et al.
Publicado: (2022)

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020)

Exciting Performance of Plasma Fibrinogen in Periprosthetic Joint Infection Diagnosis
por: Huang, Jin‐cheng, et al.
Publicado: (2021)

The Prognostic Value of Combination of Plasma Fibrinogen and CA19-9 in Non-Distant Metastatic Breast Cancer Patients Undergoing Surgery
por: Hu, Wenjing, et al.
Publicado: (2020)

Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

Depression in newly diagnosed type 2 diabetes
por: Yu, Ruan, et al.
Publicado: (2010)

Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials
por: van Soest, Robert J., et al.
Publicado: (2015)

A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease
por: Yechiel, Yaniv, et al.
Publicado: (2023)

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
por: Carretero-González, Alberto, et al.
Publicado: (2022)

Blood Viscosity in Subjects With Type 2 Diabetes Mellitus: Roles of Hyperglycemia and Elevated Plasma Fibrinogen
por: Sun, Jiehui, et al.
Publicado: (2022)

Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment
por: Hu, Xiaojuan, et al.
Publicado: (2023)

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
por: Rifkin, Robert M., et al.
Publicado: (2019)

Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real-World Analysis in the SEER Database
por: Yang, Xiaojing, et al.
Publicado: (2020)

Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy
por: Yang, Shuai, et al.
Publicado: (2020)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Impact of fibrinogen level on the prognosis of patients with traumatic brain injury: a single-center analysis of 2570 patients
por: Lv, Ke, et al.
Publicado: (2020)

Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study
por: Chen, Sijing, et al.
Publicado: (2017)

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
por: Parker, Christopher C, et al.
Publicado: (2018)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bscaku5bnkqt3f0eiiipk98v21